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Lack of the N-alpha-acetylglucosaminidase gene is re-
sponsible for the occurrence of a rare disease – the 
Sanfilippo syndrome, type B. The result of this gene 
knock-out is accumulation of glycosaminoglycans (GAGs) 
– more specifically heparan sulfate – a sulfate rich mac-
romolecule. The sulfur oxidative pathway is involved in 
the sulfate groups’ turnover in the cells. In contrast, the 
non-oxidative sulfur pathway leads mostly to formation 
of sulfane sulfur-containing compounds. The aim of our 
research was to observe an interaction between MPS IIIB 
and non-oxidative sulfur metabolism. In this work, we 
examined selected tissues (livers, kidneys, hearts and 
spleens) of 3 month old mice with confirmed accumula-
tion of GAGs. The activity and expression of three sulfur-
transferases (components of non-oxidative sulfur metab-
olism): rhodanese, 3-mercaptopyruvate sulfurtransferase 
and cystathionine γ-lyase was determined, as well as the 
sulfane sulfur level and the level of other low molecular 
sulfur-containing compounds (reduced and oxidized glu-
tathione, cysteine and cystine). In all tested tissues, the 
sulfane sulfur and/or sulfurtransferases’ activities, as well 
as the cysteine content, underwent statistically signifi-
cant changes. These correlations were also related to the 
sex of the tested animals. The obtained results indicated 
that accumulation of incompletely degraded GAGs in the 
tissues had affected the non-oxidative sulfur metabo-
lism.
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INTRODUCTION
Mucopolysaccharidosis type IIIB (MPS IIIB), also 
known as Sanfilippo syndrome B, is an autosomal reces-
sive lysosomal storage disorder caused by a homozygous 
or compound heterozygous mutation in the gene encod-
ing N-alpha-acetylglucosaminidase (NAGLU) (Andrade 
et al., 2015; Zhao et al., 1996). Sanfilippo syndrome B re-
sults from defective degradation and subsequent storage 
of heparan sulfate that is deposited in lysosomes (Klo-
ska et al., 2011; Andrade et al., 2015). Heparan sulfate, a 
member of glycosaminoglycans (GAGs) family, is a lin-
ear polysaccharide found in all animal tissues (Dreyfuss 
et al., 2009). This molecule is present on numerous cell 
surfaces as a proteoglycan or extracellular matrix compo-
nent (Iozzo, 1998; Strott, 2002). GAGs, like most other 
biomolecules, are subject to turnover, being both syn-
thesized and degraded. Proper catabolism of GAGs is 
dependent on a number of lysosomal enzymes, such as 
sulfotransferases and hydrolases. The same enzyme may 
be involved in degradation of more than one GAG, but 
the array of enzymes needed for the complete degrada-
tion of any one GAG is unique (Huxtable, 1986; Kloska 
et al., 2011). Any deficiencies in the ability to synthesize 
and/or break down GAGs are associated with various 
metabolic diseases.
MPS IIIB is classified as a rare disease due to its a 
relatively low incidence. In scientific literature, there are 
numerous publications containing phenotypic descrip-
tions and clinical features of this syndrome (Harris, 
1961; van Schrojenstein-de Valk & van de Kamp, 1987; 
Yogalingam et al., 2000; Andrade et al., 2015). The mo-
lecular mechanism of this disease is known (Zhao et al., 
1996; Tessitore et al., 2000; Tanaka et al., 2002; Mangas 
et al., 2008; Najmabadi et al., 2011). However, there are 
many aspects where the biochemistry of MPS IIIB is 
still unclear or even unknown. Therefore, understanding 
the role of GAGs and their effect on various biochemi-
cal processes in normal and pathogenic states seems to 
be very important. Even more so, because no effective 
treatment for this disease is currently available (Gaffke et 
al., 2018), despite several ongoing clinical trials with po-
tential drugs (according to information on the EU Clini-
cal Trials Register website).
Eight GAGs are known in the animal kingdom and 
most of them contain sulfate or sulfamate residues: 
chondroitin 4-sulfate, chondroitin 6-sulfate, dermatan 
sulfate, heparin, heparan sulfate, keratan sulfate (Huxta-
ble, 1986). Moreover, all tissue-organized life forms con-
tain sulfonated GAGs, but the abundancy, molecular 
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weight and type of GAGs are tissue-specific (Gomés & 
Dietrich, 1982; Prydz, 2015). Since glycosaminoglycans 
are sulfur compounds, they can be a source of sulfur 
compounds in an organism. Leaback (Leaback, 1970) es-
timated that sulfur or sulfate derived from turnover of 
GAGs in man might reach even 250 mg/day. Therefore, 
it can be assumed that there is a relationship between 
GAGs synthesis and/or storage and changes in the ac-
tivity of some sulfuric enzymes. A number of sulfatases 
are involved in GAGs metabolism, e.g. induronate sul-
fate sulfatase and N-acetylglucosamine 6-sulfate sulfatase 
are involved in the catabolism of heparan sulfate, hepa-
rin or keratan sulfate; heparan sulfate N-sulfatase (a sul-
furamidase) cleaves the N-sulfonyl group from heparan 
sulfate and heparin (Huxtable, 1986), but incorporation 
of the sulfate or sulfamate groups into GAGs is caused 
by post-polymerization modifications (N-sulfonation, 
2-O-sulfonation of iduronate, 6-O-sulfonation of glu-
cosamine) of unsulfonated GAGs (Rodén & Schwartz, 
1975; Lindahl, 1976; Riesenfeld et al., 1982). Interest-
ingly, sulfate incorporation into GAGs and the ratio of 
N- to O-sulfonation are both age-related – they decrease 
when an organism gets older. A corresponding decrease 
in sulfotransferase activities is also observed (Rodén & 
Schwartz, 1975; Lindahl, 1976; Riesenfeld et al., 1982). 
Sulfotransferases are part of the oxidative pathways of 
sulfur metabolism. They are responsible for the transfer 
of a sulfate moiety from the universal donor, 3’-phos-
phoadenosine-5’-phosphosulfate (PAPS), to various ac-
ceptors containing a hydroxyl or an amine group. The 
changes in oxidative sulfur metabolism are accompanied 
by occurrence of a mutation in the Naglu gene that re-
sults in GAGs accumulation. However, the sulfur me-
tabolism is more complex. Besides the oxidation path-
way, there is also the non-oxidative pathway of sulfur 
and GAGs accumulation that could have secondary 
effects on the disturbances of this pathway. The study 
presented here aims at investigating whether GAGs ac-
cumulation accompanying the Sanfilippo syndrome may 
indirectly affect the non-oxidative sulfur metabolism and 
if so, in what way. To date, there has been no scientific 
research on this subject.
MATERIALS AND METHODS
Animals. The first mouse breeding pairs were donat-
ed by Antoni Matilla Dueñas from the Health Sciences 
Institute Germans Trias i Pujol (Barcelona, Spain). In 
the study presented here we used the C57BL/6- mice 
wild type strain (WT) and mice with mutation B6.129S6-
Naglutm1Efn/J in the Naglu gene (Naglu-/-) (Li et al., 1999; 
jax.org). The animals were bred using heterozygotes 
which provided numerous litters. At the same time, the 
animals were not used for experiments, which guaran-
teed their constant accessibility. The animals were bred, 
kept and sacrificed in order to collect tissues in accord-
ance with the Polish Ethical Law, and the consent of the 
relevant Ethics Committees (I Local Ethical Committee 
for Animal Experiments operating at the Jagiellonian 
University in Krakow, Poland). Selected tissues were col-
lected from thirty one animals of both sexes being at a 
similar age, i.e. below 3 months. Four research groups 
were formed for this study: females (WT – 6 mice and 
Naglu-/- – 7 mice) and males (WT – 9 mice and Naglu-/- – 
9 mice).
Mice genotyping. Genotyping procedure was carried 
out using the KAPA Mouse Genotyping Kit. In the first 
step, DNA for polymerase chain reaction (PCR) was 
isolated. For this purpose, 44 μl of water, 5 μl of 10× 
KAPA Express Extract Buffer and 1 μl of 1U/μl of 
KAPA Express Extract Enzyme were added to the 2 mm 
fragments of the mice tail. The samples were incubated 
for 10 minutes at 75°C, and then enzymes were inacti-
vated for 5 minutes at 95°C. The samples were centri-
fuged and the supernatant containing DNA was ten-fold 
diluted. Subsequently, PCR reaction was carried out. The 
reaction mixture consisted of 7 μl of water, 10 μl of Fast 
Genotyping Buffer, 1.5 μl of DNA solution and 0.5 μl 
of each of the three primers: common forward primer – 
oIMR5056 (5’GTCGTCTCCTGGTTCTGGAC3’), wild 
type reverse – oIMR5057 (5’ACCACTTCATTCTGGC-
CAAT3’) and mutant reverse – oIMR8162 (5’TGGAT-
GTGGAATGTGTGCGAG3’). For genotyping, PCR 
cycling conditions were: 94°C (2 min) for the first cycle, 
94°C (20 s), 65°C (15 s), and 68°C (10 s) for the next 10 
cycles, and 94°C (15 s), 60°C (15 s), and 72°C (10 s) for 
further 28 cycles, with a final extension at 72°C (2 min). 
All of the PCR products were separated by gel electro-
phoresis on 2.0% agarose gel. The expected product size 
was as follows: mutant – 270 bp, heterozygote – 250 bp 
and 270 bp, wild type – 250 bp. Examples of the results 
are presented in Fig. 1.
Tissue collection. After the mice reached appropriate 
age, the animals were anesthetized using 2% isofuran, at 
a flow rate of 0.5 l/min. After successful anesthesia, the 
spinal cord was mechanically disrupted. The liver, kid-
ney, heart and spleen were collected from each animal. 
The tissues were washed out in cold saline, weighed and 
immediately frozen in liquid nitrogen, and kept at –80°C 
for further use. Before the assays, the tissues were ho-
mogenized in four volumes of the appropriate solution 
(0.1 M phosphate buffer, pH 7.5; 1 mM BPDS/10% 
PCA or Trizol) and centrifuged. The supernatant was 
used for determinations of enzyme activities and sulfane 
sulfur levels, determinations of low molecular weight sul-
fur-containing compounds using RP-HPLC and studies 
of gene expression.
Glycosaminoglycans (GAGs) content determina-
tion in tissues. Frozen tissues (the liver and kidney) 
were homogenized in 5 ml of the solution consisting of 
0.9% NaCl and 0.2% Triton X-100, and shaken over-
night at 4°C, which allowed to completely lyse them. 
Subsequently, the samples were centrifuged (20 min, 
3500 g, 4°C). To 50 µl of the kidney supernatant (20 µl 
for the liver), 50 µl of 8 M guanidinium chloride was 
added. The samples were incubated for 15 min at room 
temperature, and then 50 µl of a mixture containing 
0.3% sulfuric acid and 0.75% Triton X-100 was added. 
The entire volume was shaken and incubated for the 
next 15 min. In the subsequent step, 750 μl of alcian 
blue solution (0.05% alcian blue, 1% sulfuric acid, 0.25% 
Triton X-100, 0.02M guanidine chloride) was added. 
To obtain a sediment, the samples were incubated for 
Figure 1. Exemplary gel used to determine the animal geno-
type. 
For example, the animal with number 14 is a heterozygote, 15, 
WT; 16, Naglu-/- mutant, etc.
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1 hour at 4°C. Subsequently, the samples were centri-
fuged (15 min, 12 000×g, 4°C) and the supernatant solu-
tion was thoroughly removed. The pellet was resuspend-
ed in 500 µl of the solution consisting of 40% DMSO 
and 0.05 M magnesium chloride, and vigorously shaken 
to remove the dye that was not bound with GAGs 
in the pellet. The mixture was centrifuged (15 min, 
12 000×g, 4°C) to remove DMSO. Then, 500 μl of the 
solution containing 4 M guanidinium chloride and 33% 
propanol was added to the pellet to dissolve the pre-
cipitate; for this purpose, the mixture was shaken. The 
dye absorbance was measured at a wavelength equal to 
600 nm. The standard curve was prepared in the same 
way using heparan sulfate instead of tissue homogenate 
at the concentration range of 2.5–400 μg/ml.
Enzyme assay. The MPST activity was assayed ac-
cording to the method of Valentine and Frankenfeld 
(Valentine & Frankenfeld, 1974) with some modifications 
described by Wróbel and others (Wróbel et al., 2004). 
The enzyme units were defined as nmoles of pyruvate 
produced during 1 min incubation at 37°C per 1 mg of 
protein. The TST activity was assayed by the Sorbo’s 
(Sorbo, 1955) method, following a procedure described 
by Wróbel and others (Wróbel et al., 2004). The enzyme 
units were defined as nmoles of SCN–, which formed 
during 1 min incubation at 20°C per 1 mg protein. 
The CTH activity was determined according to Matsuo 
and Greenberg (Matsuo & Greenberg, 1958) method 
that was modified by Czubak and others (Czubak et al., 
2002). The enzyme activity was expressed as nmoles of 
α-ketobutyrate produced during 1 min incubation at 
37°C per 1 mg of protein.
Protein and sulfane sulfur level determination. 
Total protein content was determined by the method of 
Lowry and others (Lowry et al., 1951). The crystalline 
bovine serum albumin was used as a standard. Sulfane 
sulfur level was determined by the method of Wood 
(Wood, 1987). This method is based on cyanolysis re-
action and colorimetric detection of ferric thiocyanate 
complex ion. The level of sulfane sulfur was expressed 
as nmoles per 1 mg protein.
Low molecular sulfur-containing compounds de-
termination using RP-HPLC. The RP-HPLC (re-
versed-phase high-performance liquid chromatography) 
method of Dominic and others (Dominic et al., 2001) 
with the modifications described by Bronowicka-Adam-
ska and others (Bronowicka-Adamska et al., 2011) was 
used to determine the level of low molecular sulfur-con-
taining compounds, such as reduced (GSH) and oxidized 
(GSSG) of glutathione, cysteine and cystine. Standard 
curves were generated in the supernatant obtained from 
tissue homogenates in the range from 13 to 75 nmol of 
each compound per ml.
Isolation of total RNA. Total RNA was extracted 
from tissues using the Trizol reagent, according to the 
protocol provided by the manufacturer. Extracted RNA 
was suspended in ribonuclease free-water and was quan-
tified by measuring the absorbance at 260 nm. After 
the isolation procedure, purity of obtained RNA was 
checked. This parameter was determined as the ratio of 
the absorbance: A260 nm/A280 nm. The integrity of ob-
tained RNA was also confirmed by separation of the 
28S and 18S rRNA bands in agarose-gel electrophoresis. 
Until further studies, the RNA solutions were stored at 
–80°C.
Reverse transcription of RNA. Total RNA from a 
particular tissue was reverse-transcribed using the GoS-
criptTM Reverse Transcriptase Kit according to the man-
ufacturer’s instruction. For reverse transcription (RT) re-
action, 3 μg of total RNA was mixed with 1 μl Oligo 
d(T) primer (0.5 μg/μl) and water pretreated with dieth-
ylpyrocarbonate (DEPC-H2O) and incubated for 5 min 
at 70°C. After preincubation, other components were 
added to this mixture: 4 μl GoScriptTM 5x concentrated 
reaction buffer, 3 μl MgCl2, 1 μl deoxyribonucleotide 
triphosphates (dNTPs, 10 mM) and 1 μl RNase inhibi-
tor (20 U/μl) and 1 μl GoScriptTM Reverse Transcriptase 
(160 U/μl) in a total volume of 20 μl. The mixture was 
first incubated for 5 min at 25°C, then for 60 min at 
42°C and finally for 15 min at 70°C. If necessary, the 
solutions of complementary DNA (cDNA) were stored 
at –20°C.
Polymerase chain reaction. Expression of four 
genes (MPST, TST, CTH, GAPDH) was analyzed by 
PCR. Amplification of cDNA was run in a 25 μl reac-
tion volume that contained the following: 2 μl of syn-
thesized cDNA, 10 μM of each of gene-specific primer 
pair, 2 U/μl DNA polymerase in 10 mM buffer Tris-
HCl, pH 8.8 (supplemented with 1.5 mM MgCl2, 50 mM 
KCl, 0.1% Triton X-100), 10 mM of each dNTPs and 
DEPC-H2O. In each case, a similar reaction was also 
performed in the mixture without DNA (negative con-
trol) in order to confirm the specificity of the obtained 
reaction products. For the CTH and TST gene, PCR cy-
cling conditions were 94°C (5 min) for the first cycle, 
94°C (30 s), 60°C (30 s) and 72°C (2 min) for the next 
28 cycles, with a final extension at 72°C (8 min). The 
primer sequences were as follows: CTH forward 5’CAG-
CAAGACCCGATGCAAAG3’; CTH reverse 5’CAAA-
GCAACACCTGCCACTC3’ (304 bp), and TST forward 
5’AACCTGGGCATAAGCAACGA3’; TST reverse 
5’GGTCCACCTTCTTGTCCTGG3’ (460 bp). For the 
MPST gene, after an initial 5 min denaturation at 94°C, 
amplification was performed under the following condi-
tions: 94°C (30 s), 63°C (30 s), and 72°C (2 min) for 
30 cycles, with a final incubation at 72°C for 10 min. 
The primer sequences were as follows: forward 5’AG-
CATTTATGAAGCCCGCCT3’ and reverse 5’CCTG-
GTCACTGTCGTCGTAG3’ (420 bp). As the reference 
gene (an internal standard), GAPDH was used. GAPDH 
is a gene encoding glyceraldehyde 3-phosphate dehydro-
genase. PCR cycling conditions for the GAPDH gene 
were as follows: 94°C (5 min) – initial denaturation, and 
the amplification stages: 94°C (30 s), 59°C (30 s), and 
72°C (2 min) for the next 28 cycles with a final exten-
sion at 72°C (8 min). The primer sequences were as fol-
lows: forward 5’GTCCCAGCTTAGGTTCATCAG3’ 
and reverse 5’TTTGGCTCCACCCTTCAAGT3’ 
(404 bp). All mRNA sequences of the tested genes were 
obtained from the National Center for Biotechnology 
Information (NCBI) and all of the primers were synthe-
sized by the DNA Sequencing and Synthesis Service - 
IBB PAN in Warsaw, Poland. PCR conditions for these 
four genes were established and optimized specifically to 
meet the needs of the present study; they are published 
for the first time in this paper. All of the amplification 
reactions were performed at least 3 times to ensure the 
accuracy of results. All of the PCR products were ana-
lyzed by electrophoresis on a 2.0% agarose gel stained 
with ethidium bromide and directly visualized under UV 
light and photographed.
Statistical analysis. All of the presented experi-
ments were repeated at least three times. The data were 
expressed as arithmetic means with standard deviations 
(S.D.). Statistical significance of the differences between 
the appropriate experimental groups and the controls 
were determined using the Mann-Whitney U-test or the 
Student’s t-test. We assumed three levels of statistical 
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significance. The differences were regarded as statistically 
significant at the first level when *p<0.05, at the second 
level when **p<0.01 and at the third when ***p<0.001.
RESULTS
Selection of tissues and GAGs accumulation
Based on research previously conducted by Li and 
others (Li et al., 1999), four tissue samples (the liver, 
kidney, heart and spleen) were selected for our study. 
The investigation was performed using the same mouse 
model of MPS IIIB as Li and others (Li et al., 1999) had 
described. The accumulation of GAGs was confirmed 
in the liver and kidney. Data from measurements made 
with mice used in the experiment are presented in Ta-
ble 1. The data demonstrated that in the liver and kid-
ney, the accumulation of GAGs took place as it was 
assumed based on earlier publications (Li et al., 1999). 
Comparing the values obtained for the Naglu-/- and WT 
mice, the GAGs content was larger by an order of mag-
nitude in each case (Table 1).
The weight of the animals ranged from 20–25 g (with-
out statistical differences between groups), however, an 
interesting effect concerning the mass of particular tis-
sues was observed. The liver and spleen of the female 
and male Naglu-/- mice had greater mass in comparison 
with the same tissues obtained from the group of WT 
animals (Table 2). These differences were statistically 
significant. Additionally, the appearance of the spleens 
collected from the Naglu-/- mice group was different in 
comparison with the spleens collected from the WT 
mice (Fig. S1 in the supplement at https://ojs.ptbioch.
edu.pl/index.php/abp/). The Naglu-/- spleens were larger 
and alteration in the red color tone of the tissue was vis-
ible – the Naglu-/- spleens were darker as compared to 
the WT spleens. In macroscopic assessment of the state 
of the organs, such manifestations may be a sign of pa-
thology (Bhaumik et al., 1999), therefore, the spleens 
were also included in the study. Selection of the heart 
was associated with the low GAGs accumulation in this 
tissue as compared to the previously mentioned tissues 
(only 2–3 fold) according to the relevant literature (Li 
et al., 1999). Nevertheless, that tissue is also interesting 
from another point of view, namely the heart is strongly 
dependent on oxidative metabolism.
The low molecular weight sulfur-containing compounds’ 
level
The results obtained from the RP-HLPC measure-
ments (Table 3) showed that in the Naglu-/- mice of both 
sexes, the level of cysteine had increased almost in all 
cases: in the liver – by 2 folds (female) and 1.8 fold 
(male), in the heart – by 1.2 fold (female) and 1.1 fold 
(male) and in the spleen – by 1.6 fold (male) in com-
parison with the WT individuals. Only in the female 
Naglu-/- kidneys and spleens did the cysteine level remain 
unchanged. A contrary result was obtained in the Naglu-/- 
male kidneys, where the cysteine level was decreased 
(1.2 fold) (Table 3). Additionally, the total cysteine level 
in the tissue was also decreased in the same way (Ta-
ble 3). Another type of change was observed in the fe-
male Naglu-/- mice kidneys, where cysteine and cystine 
levels, as well as the total cysteine level, were unchanged, 
except that the cysteine/cystine ratio (CSH/CSSC) was 
by 1.4 fold lower in comparison with the female WT 
kidneys (Table 3). In the female Naglu-/- kidneys, along 
with a decrease in the CSH/CSSC ratio, the depletion 
(1.3 fold) of the reduced to oxidized glutathione GSH/
GSSG ratio (Table 3) followed. The GSH/GSSG ra-
tio depletion (1.1 fold) was also observed in the female 
Naglu-/- spleens, but in this case it was caused by a re-
duction in the level of reduced and oxidized glutathione, 
as well as the total glutathione level by about 1.3, 1.2 
and 1.3 fold, respectively. In the female Naglu-/- kidneys, 
the depletion of the GSH/GSSG ratio was not associ-
ated with fluctuations in these parameters (Table 3). Our 
results (Table 3) indicated that in two cases a GSH/
Table 1. GAGs accumulation in the selected tissues of both, the 
WT and Naglu-/- animals.
Values represent an arithmetic mean ±S.D. of 8–10 animals.
Experimental group GAG[mg/g of wet tissue]
Liver
Female
WT 0.049±0.003
Naglu-/- 0.498±0.096
Male
WT 0.057±0.005
Naglu-/- 0.615±0.251
Kidney
Female
WT 0.082±0.017
Naglu-/- 1.159±0.252
Male
WT 0.116±0.016
Naglu-/- 1.017±0.044
Table 2. Average tissue weight collected from individual re-
search groups.
Values represent an arithmetic mean ±S.D. of 6–9 animals. *p<0.05; 
(Mann-Whitney U-test)
Experimental group Average tissue weight[g]
Liver
Female
WT 1.053±0.112
Naglu-/- 1.384±0.140*
Male
WT 1.246±0.130
Naglu-/- 1.703±0.173*
Kidney
Female
WT 0.275±0.035
Naglu-/- 0.264±0.038
Male
WT 0.329±0.032
Naglu-/- 0.359±0.067
Heart
Female
WT 0.132±0.018
Naglu-/- 0.121±0.012
Male
WT 0.146±0.021
Naglu-/- 0.156±0.026
Spleen
Female
WT 0.103±0.017
Naglu-/- 0.123±0.019*
Male
WT 0.082±0.014
Naglu-/- 0.105±0.019*
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Table 3. Changes in the level of oxidized and reduced forms of glutathione, cysteine and cystine, total glutathione and total cysteine 
and the ratio between the reduced and oxidized form of glutathione/cystine in selected tissues of both WT and Naglu-/- mice.
Values represent an arithmetic mean ±S.D. of 3–4 animals, with each determination consisting of 1–2 assays. *p<0.05; (Mann-Whitney U-
test)
Experimental 
group
GSH GSSG
Total gluta-
thione 
(2GSSG+GSH) GSH/GSSG
CSH CSSC Total cysteine (2CSSC+CSH) CSH/CSSC
nmole/mg protein nmole/mg protein
Liver
Female
WT 56.52±5.43 2.27±0.17 61.06±5.41 24.99±3.15 0.60±0.09 < LOQ NA NA
Naglu-/- 62.57±2.09 2.89±0.15* 68.35±1.79* 21.72±1.81 1.25±0.18* ND NA NA
Male
WT 46.25±2.71 2.78±0.35 51.20±2.77 20.71±4.13 0.81±0.05 <LOQ NA NA
Naglu-/- 49.89±4.00 2.09±0.17* 54.07±4.35 23.85±0.16 1.42±0.10* <LOQ NA NA
Kideny
Female
WT 9.47±0.79 1.06±0.19 11.59±1.03 9.13±1.41 10.09±3.20 1.53±0.29 13.16±3.81 6.30±1.24
Naglu-/- 8.69±3.32 1.24±0.44 11.16±4.20 6.97±0.28* 7.36±0.75 1.68±0,09 10.72±0.87 4.38±0.36*
Male
WT 9.03±2.71 1.07±0.23 11.18±3.17 8.31±0.77 24.50±1.29 2.02±1.04 28.55±1.91 15.09±7.81
Naglu-/- 7.63±0.11 0.97±0.17 9.56±0.24 8.07±1.36* 20.75±0.34* 1.50±0.37 23.57±1.29* 16.18±3.70
Heart
Female
WT 6.72±0.43 1.55±0.08 9.83±0.27 4.34±0.50 1.93±0.01 <LOQ NA NA
Naglu-/- 9.95±0.32* 1.55±0.12 13.04±0.56* 6.45±0.30* 2.38±0.01* <LOQ NA NA
Male
WT 6.56±1.04 2.44±0.32 11.44±0.40 2.73±0.78 0.87±0.01 <LOQ NA NA
Naglu-/- 8.46±0.99 1.86±0.42 12.17±1.29 4.73±1.37 0.95 ±0.02* 0.46±0.12 1.59±0.51 2.16±0.56
Spleen
Female
WT 27.52±1.86 3.60±0.03 34.72±1.81 7.65±0.57 1.18±0.13 < LOQ NA NA
Naglu-/- 20.11a 2.95a 26.00a 6.82a 1.17a < LOQ NA NA
Male
WT 15.49±1.15 3.01±0.10 21.50±1.36 5.15±0.21 0.86±0.07 <LOQ NA NA
Naglu-/- 17.86±0.63* 3.07±0.04 23.69±0.55* 5.73±0.27* 1.37±0.16* <LOQ NA NA
 astandard deviation was not calculated because of a low number of results; <LOQ, lower than the limit of quantification of the method; NA, not 
applied; ND, not detected; The data presented are arithmetic means of 2–8 determinations. The limit of detection for glutathione (GSH) in the 
RP-HPLC method is equal to 0.01 [nM·ml–1] and for oxidized form of glutathione (GSSG) – 0.1 [nM·ml–1]. The limit of quantification for GSH is 0.1 
[nM·ml–1] and GSSG: 1 [nM·ml–1] (Dominic et al., 2001). The limit of detection for cysteine (CSH) was defined by the RP-HPLC method and is equal 
to 0.01 [nM·ml-1] and for cystine (CSSC) – 0.1 [nM·ml–1]. The limit of quantification for CSH: 0.1 [nM·ml–1] and the CSSC – 1 [nM·ml–1] (Dominic et al., 
2001).
Figure 2. L-cysteine metabolism in mammalian cells (Cys-S-S-S-Cys, thiocystine; Cys-S-S-Cys, cystine; Cys-S-SH, thiocysteine; sulfane 
sulfur in the picture is underlined and bold).
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GSSG ratio increase was observed: in the female Naglu-/- 
hearts (1.5 fold) and male Naglu-/- spleens (1.1 fold). This 
may be a secondary effect of an increase, in both cases, 
of the reduced form of glutathione and total glutathione 
level (female Naglu-/- hearts: GSH 1.5 fold, total glu-
tathione level – 1.3 fold; male Naglu-/- spleens: GSH 1.2 
fold, total glutathione level – 1.1 fold) (Table 3). In the 
female Naglu-/- livers, an increased level of the oxidized 
(1.3 fold) and total glutathione (1.1 fold) could be also 
observed, but in this case, the changes did not cause any 
alterations in the GSH/GSSG ratio (Table 3).
The sulfane sulfur level
In the liver, kidney and heart of the WT mice (both 
female and male), the content of sulfane sulfur was at a 
similar level, in the range of 110–205 nmol/mg protein 
(Table 4), and only in the WT spleens was the determined 
sulfane sulfur level different, amounting to one-half of the 
above values: 77 nmol/mg protein for the female and 60 
nmol/mg protein for the male mice (Table 4). Taking into 
account sex of the animals, the WT spleens and Naglu-/- 
livers differed significantly in the level of sulfane sulfur 
– in the males, the level was lower than in the females 
(Table 4). To make data more clearly arranged, Table 4 
has been rearranged to show differences concerning sex 
in a better way and added in supplemental information as 
Table S1 (at https://ojs.ptbioch.edu.pl/index.php/abp/). 
However, a comparison of the WT and Naglu-/- groups 
of mice indicated that only in spleens of the male Na-
glu-/- mice was there a statistically significant (p<0.05) in-
crease in the sulfane sulfur level observed (Table 4). On 
the other hand, a statistically significant (p<0.05) decrease 
in the sulfane sulfur level was noted only for the male 
Naglu-/- mice in the liver and kidney (Table 4). The knock-
out of the Naglu gene in the female individuals did not 
affect the sulfane sulfur level changes. In all of the exam-
ined female Naglu-/- tissues, the sulfane sulfur content was 
at the level comparable to the WT group (Table 4). The 
changes in the level of sulfane sulfur in particular tissues 
affect the fluctuation of sulfurtransferases’ activities, as 
well as cysteine availability to glutathione synthesis (Fig. 2) 
– the most important antioxidant produced by the body.
Changes in activity and expression of three enzymes 
participate in non-oxidative sulfur metabolism in the 
selected mice tissues
Rhodanese (TST, EC: 2.8.1.1)
Based on the results presented in Table 4, it could 
be stated that the highest activity of TST was noted 
in the liver, lower - in the kidney and heart, and the 
lowest activity was observed in the spleen. Moreover, 
there were significant differences between the sexes in 
the values of TST activity in all tested tissues (Table 
S1 in the supplement at https://ojs.ptbioch.edu.pl/in-
dex.php/abp/). In the liver, heart and spleen of the 
female mice, both WT and Naglu-/-, the TST activity 
was higher in comparison to the activity of the en-
zyme determined in the male mice (Table S1 in the 
supplement at https://ojs.ptbioch.edu.pl/index.php/
abp/). Only in WT and Naglu-/- kidneys were these re-
sults divergent – the male mice were characterized by 
a higher activity of TST than the female (Table S1 in 
the supplementat at https://ojs.ptbioch.edu.pl/index.
php/abp/). Statistically significant differences in the 
TST activity between the WT and Naglu-/- mice were 
Table 4. Level of sulfane sulfur and sulfurtransferases activity in selected tissues of both the WT and Naglu-/- animals.
Values represent the arithmetic mean ± S.D. of 3–4 animals, which each determination consisting of 4–20 assays. *p<0.05; **p<0.01; 
***p<0.001 (Student’s t-test). ND – not detected
Experimental group Sulfane sulfur [nmol/mg protein]
TST 
[nmol/mg protein∙min]
MPST
[nmol/mg protein∙min]
CTH 
[nmol/mg protein∙min]
Liver
Female
WT 120.99±15.98 520.16±47.72 345.37±80.70 3.268±0.524
Naglu-/- 115.91±8.22 548.80±43.20 283.05±73.24 2.026±0.051***
Male
WT 109.79±18.00 433.33±28.91 285.28±112.64 2.945±0.303
Naglu-/-  96.56±7.26* 459.64±58.44 262.14±68.19 1.961±0.098***
Kideny
Female
WT 142.15±17.27 182.95±5.60 339.83±24.55 0.919±0.182
Naglu-/- 135.45±12.59 191.03±25.40 258.82±49.46** 1.080±0.143*
Male
WT 145.20±21.24 224.75±30.00 323.56±88.76 0.718±0.114
Naglu-/- 127.07±13.21* 214.65±32.54 244.34±60.73* 0.779±0.124
Heart
Female
WT 193.19±30.68 37.61±7.55 78.75±18.73 0.099±0.073
Naglu-/- 199.26±29.93 41.18±3.51 89.93±12.72  ND
Male
WT 204.32±21.57 32.90±4.24 67.56±15.49 0.156±0.032
Naglu-/- 214.23±16.98 38.87±2.33*** 69.57±19.45 0.206±0.040
Spleen
Female
WT 77.16±5.87 31.65±1.12 52.10±9.93 0.134±0.036
Naglu-/- 67.03±13.50 24.11±2.36*** 34.99±13.49 0.237±0.048**
Male
WT 60.39±1.24 13.09±1.27 59.56±6.41 0.041±0.000
Naglu-/- 70.94±10.13* 16.35±0.00** 41.28±7.91**  ND
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observed only in the heart and spleen. The TST ac-
tivity in the male Naglu-/- hearts (p<0.001), as well as 
in the male Naglu-/- spleens (p<0.01), were higher in 
comparison to appropriate WT control group (Ta-
ble 4). Interestingly, it was observed that in the fe-
male Naglu-/- spleens the TST activity was decreased 
and that result was statistically significant (p<0.001). 
However, the expression measurements (Fig. 3) dem-
onstrated no differences in the TST expression in the 
tested tissues.
3-mercaptopyruvate sulfurtransferase (MPST, EC: 2.8.1.2)
According to the data collected in Table 4, the high-
est activity of MPST was shown in the WT kidney and 
liver, the lowest – in the spleen. There were no major 
differences associated with the MPST activity in the se-
lected tissues between the female and male mice, except 
one case – the Naglu-/- kidneys – where the TST activity 
in female mice was higher in comparison to the activity 
of the enzyme determined in the male individuals (Ta-
ble S1 in the supplement at https://ojs.ptbioch.edu.pl/
index.php/abp/). A statistically significant decrease in 
the MPST activity was observed in the Naglu-/- kidneys, 
both female (p<0.01) and male (p<0.05), as well as in 
the male Naglu-/- spleens (p<0.01) (Table 4). In other tis-
sues, the MPST activity remained unchanged (Table 4). 
Taking into consideration the expression measurements 
illustrated in Fig. 3, it could be noted that there were 
no significant differences in the expression of the MPST 
gene in the liver, heart and spleen, but the results ob-
tained for the male kidney indicated that the MPST ex-
pression in the Naglu-/- mice was higher in comparison 
to the level of the expression determined in the WT 
male kidneys (Fig. 3).
Cystathionine γ-lyase (CTH, EC: 4.4.1.1)
Based on the data shown in Table 4, it can be said 
that the highest CTH activity was detected in the mice 
liver. In general, the CTH activity in the selected tis-
sues was very low in comparison to the TST or MPST 
activity (Table 4), therefore, it is difficult to postulate 
that there was any difference between the females and 
males, although the results demonstrated a slight de-
crease in the CTH activity in the male WT and Naglu-/- 
livers and kidneys, as well as the WT spleens (Table S1 
in the supplement at https://ojs.ptbioch.edu.pl/index.
php/abp/). However, in both the female and male Na-
glu-/- livers, the decrease in the CTH activity was demon-
strated (p<0.001). In contrast, in the female Naglu-/- kid-
neys and spleens, the activity of CTH had significantly 
increased (p<0.05 and p<0.01, respectively) (Table 4). In 
other tissues, the CTH activity remained unchanged (Ta-
ble 4). Furthermore, the expression studies (Fig. 3) did 
not demonstrate any differences in the level of the CTH 
gene expression in the tested tissues.
DISCUSSION
In our experiments, we used mice that did not ex-
ceed 3 months of life. They were healthy and have not 
shown any pathological and behavioral changes to date, 
although such changes may become more visible with 
time. The Naglu-/- mice, both female and male, revealed 
the accumulation of GAGs, more specifically heparan 
sulfate (Table 1), that are characteristic for some lyso-
somal storage diseases. These results are in accordance 
with the results previously obtained by Li and others 
(Li et al., 1999). The highest accumulation of GAGs oc-
curred in the liver and kidney. Li and others (Li et al., 
Figure 3. RT-PCR analysis. 
(A) Genes expression in various tissues of mice. (B) The relative expression level of TST, MPST and CTH in selected tissues of mice. Densi-
ties of bands were normalized using signal for GAPDH gene.
574           2019M. Kaczor-Kamińska and others
1999) also observed that the spleen and heart were able 
to accumulate GAGs, although the GAGs level in these 
tissues was only a small percentage of the level measured 
in the liver and kidney. Interestingly, we noted that the 
liver and spleen collected from the Naglu-/- mice had a 
statistically significant larger mass in comparison to the 
appropriate WT tissues (Table 2). In macroscopic assess-
ment of the state of the organs, we also observed that 
the appearance of the spleen (Fig. S1 in the supplement 
at https://ojs.ptbioch.edu.pl/index.php/abp/) was dif-
ferent, depending on the experimental group the mouse 
belonged to (Naglu-/- or WT group). A similar observa-
tion was made by Bhaumik and others (Bhaumik et al., 
1999), but they used older mice (aged 9 months). How-
ever, Bhaumik and others (Bhaumik et al., 1999) showed 
that an adult mouse affected by MPS III suffered of liv-
er enlargement and hepatosplenomegaly. The age of the 
mice that were used by Bhaumik and others (Bhaumik 
et al., 1999) could reflected the final MPS III stages, in 
contrast to our animals. From the point of view of the 
knowledge on MPS, the most important disease stages 
are the earliest ones (this is correlated with the average 
life-span of a MPS sufferer) and thus they were the ones 
we examined.
The deficiency of one enzyme involved in degrada-
tion of GAGs is often accompanied by an increase in 
other enzymes in other enzymatic pathways (Li et al., 
1999), but we are not able to state how many other 
biochemical processes may be disturbed by only one 
change that causes a pathogenic state. Therefore, in this 
work, we tried to establish the effect of accumulation 
of incompletely degraded sulfur-containing compounds 
(GAGs) on some parameters involved in non-oxidative 
metabolism of sulfur. According to the results presented 
in Table 3, it could be said that GAGs accumulation in 
particular tissues caused an increase in the cysteine level 
in the majority of cases. Cysteine is a component and/
or substrate for a variety of anabolic and catabolic en-
zymes (Stipanuk, 2004), as well as biologically impor-
tant factors, such as glutathione, coenzyme A or metal-
lothioneins (Ruttkay-Nedecky et al., 2013). Apart from 
this observation, in the male Naglu-/- liver and heart, the 
remaining low molecular weight sulfur-containing com-
pounds were unchanged (Table 3). Nevertheless, the in-
crease in cysteine level contributes to an increase in the 
content of cell reductants, such as glutathione or thiore-
doxin, that can effectively counteract a locally occurring 
oxidative stress (Nagahara et al., 2007). Jacquez and oth-
ers (Jacquez et al., 2016) observed that the disturbance 
of redox balance could be GAGs- and pro-inflammatory 
cytokine-related. We documented the redox imbalance in 
two cases. In the female Naglu-/- hearts and male Naglu-/- 
spleens (Table 3), the GSH/GSSG ratio was increased. 
The GSH/GSSG ratio is the major redox couple that 
determines the antioxidative capacity of the cells (Wu et 
al., 2004). The higher the GSH/GSSG ratio value, the 
more stressors appear in the cell environment. Howev-
er, based on the results (Table 3), it could be said that 
GAGs accumulation in the heart (Naglu-/-, female) and 
spleen (Naglu-/-, male) boosts the cysteine production 
(elevated level) and this cysteine is used to produce or 
restore the reduced form of glutathione (elevated level). 
This process seems to be efficient, because the total glu-
tathione level is also elevated in both tissues and despite 
the unfavorable conditions in the cells (the increased 
GSH/GSSG ratio), the number of cellular reductants 
(GSH, CSH) increases. In the female Naglu-/- livers, the 
total glutathione level was also increased (Table 3), but 
in this particular case it was caused by the increased lev-
el of oxidized glutathione. The cysteine residue of GSH 
can be readily oxidized nonenzymatically to disulfide 
(GSSG) by e.g. free radicals and reactive oxygen/nitro-
gen species (Wu et al., 2004), but under our experimental 
conditions the oxidation of reduced glutathione did not 
adversely affect the GSH/GSSG ratio (Table 3). Slightly 
different results – in comparison with the male Naglu-/- 
spleens – were obtained in the female Naglu-/- spleens 
(Table 3), where all of the gutathione-related parameters 
(GSH, GSSG, total glutathione and GSH/GSSG ratio) 
were decreased. Despite the cysteine level that remained 
unchanged, in the female Naglu-/- spleens, GAGs accu-
mulation causes some unknown processes that lead to 
consumption of glutathione resources and a decreased 
GSH/GSSG ratio (Table 3). Similarly, in the female Na-
glu-/- kidneys, the GSH/GSSG as well as CSH/CSSC ra-
tio had decreased, but these changes were not associated 
with any disturbances in the reduced and oxidized glu-
tathione content, as well as the level of both cysteine and 
cystine (Table 3). Only in one case was a decrease in the 
cysteine level noted (Table 3). That result was obtained 
in the male Naglu-/- kidney. As a consequence, the total 
cysteine level was also decreased (Table 3). The results 
are closely related to the results obtained from measure-
ments of sulfane sulfur level and activities of enzymes 
that participate in formation (CTH mostly) and/or trans-
port of sulfane sulfur atom-containing compounds (TST, 
MPST) (Table 4) in the non-oxidative sulfur pathway.
Stipanuk (Stipanuk, 2004), Stipanuk and Ueki (Sti-
panuk & Ueki, 2011) and Wróbel and others (Wróbel 
et al., 2000) described in detail oxidative and/or non-
oxidative metabolic pathways of sulfur, but to better 
understand the processes described in the paper pre-
sented here, Fig. 2 can be also useful. Based on the re-
sults presented in Table 4, it could be said that in the 
male Naglu-/- spleens, an increased cysteine level was ac-
companied by an increased level of sulfane sulfur-con-
taining compounds. It means that cysteine – apart from 
glutathione synthesis (Table 3) – is also redirected to a 
non-oxidative pathway, in which sulfane sulfur-contain-
ing compounds (Table 4) and hydrogen sulfide can be 
formed. In the male Naglu-/- spleens, the TST activity is 
increased (Table 4), and TST is responsible for transfer-
ring sulfur atoms from various donors (sulfane sulfur-
containing compounds) to various acceptors (Nagasawa 
et al., 2007), while the MPST activity is decreased (only 
in this case a difference in gene expression was observed 
– the level of the MPST gene expression increased in 
relation to the level marked in the control group; Fig. 3). 
MPST catalyzes transfer of the sulfane sulfur atom from 
3-mercaptopyruvate to various acceptors, producing sul-
fane sulfur-containing compounds (e.g. thiosulfate) and 
also releases it as hydrogen sulfide (Nandi et al., 2000; 
Williams et al., 2003; Nagasawa et al., 2007). Possibly, un-
der experimental conditions used here, the reaction cata-
lyzed by MPST had a slower course (occurred at a lower 
frequency) or GAGs accumulation in the cells contrib-
uted to producing other, not yet fully defined chemical 
compounds and/or substances that would be able to 
inhibit the enzyme activity by covalent bonds with the 
redox-active cysteine residue (-SH) located in the active 
site of the enzyme or by oxidation of its -SH residues 
to inactive -SOH groups. Changes in the sulfane sulfur 
level (decrease in that level) were also observed in the 
male Naglu-/- livers and kidneys (Table 4). Additionally, 
in the kidney, a decrease in the MPST activity was ob-
served (Table 4), while in the liver, the MPST activity re-
mained at the same level as determined in the male WT 
liver (Table 4). On the other hand, in the liver, a dimin-
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ished CTH activity was observed, while in the kidney, it 
remained unchanged (Table 4). CTH is involved in sul-
fane sulfur generation in the cells (Toohey, 1989). De-
creasing the activity of this enzyme, when it is associated 
with decreasing the sulfane sulfur level, may be the re-
sult of a decrease in the available pool of sulfane sulfur-
containing compounds that are substrates for reactions 
catalyzed by CTH. A drop in the CTH activity was also 
observed in the female Naglu-/- livers, but the reduction 
was not related to changes in the sulfane sulfur levels 
(Table 4). On the other hand, it is directly or indirectly 
related to GAGs accumulation – in the cells, undigested 
GAGs might contribute to formation of some substanc-
es that subsequently might be related to a decrease in 
the CTH activity (inhibition of the enzyme), however, 
further studies are necessary. Contrariwise, an increase 
in the CTH activity was noted in two cases: the female 
Naglu-/- kidneys and spleens (Table 4). Despite the fact 
that sulfane sulfur remained unchanged in these tissues, 
the differences in the CTH activity provided us with the 
information that a turnover of sulfane sulfur-containing 
compounds occurred in the cells (Table 4). The same 
information was obtained from the male Naglu-/- hearts, 
where only the TST activity was elevated, but this en-
zyme participates in turnover of sulfane sulfur-containing 
compounds (Table 4). It means that cysteine was used 
in the non-oxidative sulfur pathway, although reductions 
in the glutathione level and GSH/GSSG were observed 
(Table 3). With the boosting activity of CTH, a decrease 
in the MPST activity (female Naglu-/- kidneys) and a de-
crease in the TST activity (female Naglu-/- spleens) were 
observed (Table 4). Decrease in the above activities may 
be caused by the same factors that have been presented 
above in the description of the possible MPST inhibition 
that took place in the male Naglu-/- spleens. In the case 
of the studied enzymes, we did not observe any changes 
in the levels of their expression (Fig. 3).
Furthermore, the literature provides information ad-
dressing the level of a particular sulfurtransferase (TST, 
MPST, CTH) activity levels in selected tissues, and based 
on the above data, the sulfurtransferases activities are the 
highest in the liver and kidney (Aminlari et al., 2002; Na-
gasawa et al., 2007) – our results (Table 4) are in accord-
ance with these findings.
CONCLUSIONS
Accumulation of incompletely degraded GAGs in par-
ticular tissues contributes to increasing cysteine levels in 
the majority of cases: the Naglu-/- livers (both female and 
male), Naglu-/- hearts (both female and male) and Naglu-/- 
male spleens; this may result in changes in non-oxidative 
sulfur metabolism.
Excess of GAGs in the cells can lead to inhibition 
of PAPS formation from cysteine. An elevated level of 
cysteine in the cells can in turn accelerate its non-oxida-
tive metabolism.
In all tissues tested, the sulfane sulfur and/or sul-
furtransferases activities (components of non-oxidative 
sulfur metabolism) underwent statistically significant 
changes, which can also suggest that GAGs accumula-
tion affects sulfane sulfur-containing compounds level 
and the level and/or activity of enzymes participating in 
their turnover.
Changes observed in non-oxidative metabolism of sul-
fur are related to the sex of the tested animals.
The obtained results confirm the assumed hypothesis 
and demonstrate that GAGs accumulation affects the 
non-oxidative sulfur metabolism.
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